在严重喘中Omalizumab过渡:影响切换决策和最佳反应时间的因素
Mona Al-Ahmad1,2, Asmaa Ali2,3,4, Ahmed Maher2
1Department of Microbiology, College of Medicine, Kuwait University, Kuwait City, Kuwait.
概括
切换严重喘患者从奥马利祖马布早期,在5年内,特别是在高唾液异位素,可能会改善生物治疗反应. 获得替代生物制剂的机会影响了这种早期切换时间.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘管理往往涉及生物疗法,如奥马利祖马布.
- 治疗决策,包括转换生物药物,需要仔细考虑患者特定的因素和治疗持续时间.
- 对替代生物治疗方法的获取有限可能会影响治疗途径.
研究的目的:
- 评估在严重喘患者中从奥马利祖马布转换为其他生物疗法的有效性.
- 为了确定影响决定从奥马利祖马布转换的因素.
- 确定切换的最佳时间,以实现有利的生物反应.
主要方法:
- 在科威特的第三级过敏中心进行了回顾性研究.
- 包括116名严重喘患者,其中33人获得多种生物治疗.
- 对继续服用奥马利祖马布的患者与转换为另一种生物药物的患者进行比较分析.
主要成果:
- 22.4%的患者从奥马利祖马布转换.
- 更高的唾液乙氨基酸水平,男性性别和并发症 (缺血性心脏病,慢性鼻炎,鼻) 与切换有关.
- 每增加1%的唾液乙氨基酸细胞都会使切换的可能性增加一倍.
- 获得替代生物制剂的患者比获得有限 (8.9年) 的患者更早 (4.9年) 转换.
- 治疗持续时间少于5.5年预测了良好的反应,具有高灵敏度和特异性 (89%和100%).
结论:
- 在5年内从奥马利祖马布早期过渡可能会改善严重喘的治疗结果.
- 更高的唾液乙氨基酸细胞计数是考虑切换的关键指标.
- 替代生物疗法的可用性对于促进及时治疗调整至关重要.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
326
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
326
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:20Asthma: Pathogenesis and Management
433
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
433
01:19Antiasthma Drugs: Leukotriene Modifiers
338
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
338
01:30Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
01:29Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K